Article: [Docetaxel plus S-1 as a second-line chemotherapy for metastasis or recurrence of esophageal cancer].
Gan to kagaku ryoho. Cancer & chemotherapy
2012 Volume 39, Issue 2, Page(s) 227–230
Abstract: ... of docetaxel plus S-1 used as a second line therapy. We reviewed 21 patients(postoperatively, 11; after ... mediastinum(n=1), and pleura(n=1). Docetaxel 30mg/m2 was infused every 2 weeks, and S-1 80mg/m2 was taken ... S-1 might be a feasible regimen as a second-line chemotherapy for metastasis or recurrence ...
Abstract | Although chemotherapy consisting of cisplatin and 5-fluorouracil(CF)has been a standard regimen for esophageal cancer, it might be difficult to use continuously. This study evaluated the response and safety of docetaxel plus S-1 used as a second line therapy. We reviewed 21 patients(postoperatively, 11; after definitive chemoradiotherapy, 8; after chemotherapy, 2) who received chemotherapy between 2006 and 2010. Metastatic or recurrent disease was detected in the organs(n=8), lymph nodes(n=8), main tumors(n=3), mediastinum(n=1), and pleura(n=1). Docetaxel 30mg/m2 was infused every 2 weeks, and S-1 80mg/m2 was taken for 2 weeks, then with 2 weeks rest until progression. Almost all of the patients received docetaxel in the outpatient chemotherapy room. The median number of treatment cycles was 3, ranging from 1-12. Among the 14 patients with a therapeutic response, three(21%)achieved PR, 8 showed SD, and 3 had PD. Toxicity which included grade 3/4 was neutropenia in 6 patients, and anemia in one patient. After a follow-up of over one year, the median overall survival was 10 months, and the one-year survival rate was 38%. Docetaxel plus S-1 might be a feasible regimen as a second-line chemotherapy for metastasis or recurrence of esophageal cancer. |
---|---|
MeSH term(s) | Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Drug Combinations ; Esophageal Neoplasms/drug therapy ; Esophageal Neoplasms/pathology ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis ; Oxonic Acid/administration & dosage ; Oxonic Acid/adverse effects ; Recurrence ; Salvage Therapy ; Taxoids/administration & dosage ; Taxoids/adverse effects ; Tegafur/administration & dosage ; Tegafur/adverse effects |
Chemical Substances | Drug Combinations ; Taxoids ; S 1 (combination) (150863-82-4) ; Tegafur (1548R74NSZ) ; docetaxel (15H5577CQD) ; Oxonic Acid (5VT6420TIG) |
Language | Japanese |
Publishing date | 2012-02 |
Publishing country | Japan |
Document type | English Abstract ; Journal Article |
ZDB-ID | 604842-0 |
ISSN | 0385-0684 |
ISSN | 0385-0684 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.B 2573: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.